Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001650664-25-000161

SVP, Chief Financial Officer sold 461 shares at $2.15 ($993)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Parison Amy · SVP, Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-03 Sale : show line 1 in the form 10b5-1 −461 $2.15 $993 15,908 D
Open-market sales · 461 sh · avg $2.15 · $993
Loading xslF345X05/wk-form4_1764884284.xml…